Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Millward

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Development of breast cancer during long-term tamoxifen therapy for lymphangioleiomyomatosisM J Millward, B M Cantwell
Australian and New Zealand Journal of Medicine|August 1, 1988
Cardiac arrest--a manifestation of 5-fluorouracil cardiotoxicityM J Millward, V Ganju, M Buck
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Fixed dose short course mitomycin C with vincristine in advanced pre-treated breast cancerM J Millward, A Hendrick, B M Cantwell
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Second line treatment options in advanced colorectal cancerJ M Stewart, M J Millward, J R Zalcberg
Cancer|June 1, 1990
Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancerM J Millward, A L Harris, B M Cantwell
Lancet (London, England)|June 8, 1991
Epidermal growth factor receptors and doxorubicin plus ifosfamide/mesna in recurrent breast cancerB M Cantwell, C Hennessy, M J Millward, et al.
Cancer|July 15, 1997
Fatal pulmonary toxicity resulting from treatment with gemcitabineN Pavlakis, D R Bell, M J Millward, et al.
British Journal of Obstetrics and Gynaecology|November 1, 1979
Amniotic fluid squalene and fetal maturityS J Wysocki, R Hähnel, M J Millward, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 23, 2008
Phase II study of acivicin in patients with recurrent high grade astrocytomaI N Olver, M Green, M J Millward, et al.
Oncology|January 1, 1994
High-dose (480 mg/day) tamoxifen with etoposide: a study of a potential multi-drug resistance modulatorM J Millward, E A Lien, A Robinson, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Development of breast cancer during long-term tamoxifen therapy for lymphangioleiomyomatosisM J Millward, B M Cantwell
Australian and New Zealand Journal of Medicine|August 1, 1988
Cardiac arrest--a manifestation of 5-fluorouracil cardiotoxicityM J Millward, V Ganju, M Buck
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Fixed dose short course mitomycin C with vincristine in advanced pre-treated breast cancerM J Millward, A Hendrick, B M Cantwell
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Second line treatment options in advanced colorectal cancerJ M Stewart, M J Millward, J R Zalcberg
Cancer|June 1, 1990
Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancerM J Millward, A L Harris, B M Cantwell
Lancet (London, England)|June 8, 1991
Epidermal growth factor receptors and doxorubicin plus ifosfamide/mesna in recurrent breast cancerB M Cantwell, C Hennessy, M J Millward, et al.
Cancer|July 15, 1997
Fatal pulmonary toxicity resulting from treatment with gemcitabineN Pavlakis, D R Bell, M J Millward, et al.
British Journal of Obstetrics and Gynaecology|November 1, 1979
Amniotic fluid squalene and fetal maturityS J Wysocki, R Hähnel, M J Millward, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 23, 2008
Phase II study of acivicin in patients with recurrent high grade astrocytomaI N Olver, M Green, M J Millward, et al.
Oncology|January 1, 1994
High-dose (480 mg/day) tamoxifen with etoposide: a study of a potential multi-drug resistance modulatorM J Millward, E A Lien, A Robinson, et al.
Pageof 6